Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Short Interest Up 6.0% in October

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) was the recipient of a significant growth in short interest in the month of October. As of October 15th, there was short interest totalling 1,230,000 shares, a growth of 6.0% from the September 30th total of 1,160,000 shares. Based on an average daily trading volume, of 341,700 shares, the short-interest ratio is presently 3.6 days. Approximately 2.2% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. UBS Group boosted their target price on Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a research note on Friday, August 9th. Royal Bank of Canada lifted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a research report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a research report on Friday, August 9th.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $4.65 on Friday. Aveanna Healthcare has a 12 month low of $1.34 and a 12 month high of $5.95. The stock’s fifty day moving average price is $5.19 and its 200-day moving average price is $3.81.

Aveanna Healthcare (NASDAQ:AVAH) last released its earnings results on Thursday, August 8th. The company reported ($0.01) EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.03. The company had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. On average, equities research analysts forecast that Aveanna Healthcare will post -0.09 earnings per share for the current year.

Institutional Investors Weigh In On Aveanna Healthcare

Institutional investors have recently modified their holdings of the business. Acadian Asset Management LLC boosted its position in shares of Aveanna Healthcare by 185.6% during the first quarter. Acadian Asset Management LLC now owns 29,385 shares of the company’s stock valued at $72,000 after buying an additional 19,096 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Aveanna Healthcare by 1.8% in the first quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock valued at $6,402,000 after acquiring an additional 44,970 shares during the period. Renaissance Technologies LLC lifted its holdings in Aveanna Healthcare by 155.8% in the second quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after acquiring an additional 96,600 shares during the period. Bank of New York Mellon Corp lifted its holdings in Aveanna Healthcare by 6.6% in the second quarter. Bank of New York Mellon Corp now owns 149,761 shares of the company’s stock valued at $413,000 after acquiring an additional 9,243 shares during the period. Finally, SG Americas Securities LLC bought a new position in Aveanna Healthcare in the third quarter valued at about $101,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.